Vaginal Ecosystem and Network in the United States Study
This observational study, called the Vaginal Ecosystem and Network in the United States Study, is looking at how the balance of bacteria and other tiny organisms in the vagina (the vaginal microbiome) affects conditions like Bacterial Vaginosis, Candidiasis (yeast infections), and Urinary Tract Infections. Researchers will collect a vaginal swab from you to analyze the microbiome using special tests (PCR and NGS). The main goal is to understand how different microbiome patterns are linked to these conditions. The study aims to enroll 3250 healthy women, aged 18 to 89, who are not pregnant or trying to conceive. The study's success will be measured by analyzing the microbiome from your swab on the first day.
- Study design
- This is an observational study with a planned enrollment of 3250 participants. It involves collecting vaginal swab samples from healthy individuals and those with diagnosed gynecological conditions.
- What's involved
- You would provide a vaginal swab sample for analysis. The study does not specify additional visits or procedures.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, microbiome analysis, is measured at Day 1. No further follow-up is specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Vaginal Ecosystem and Network in the United States Study
At a glance
Conditions
NCT06472765
Where you'd take part
This study runs at 21 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Amber Wellness Group
Portland, Oregonno site contact published
Camel City Women's Wellness
Winston-Salem, North Carolinano site contact published
Center for Pelvic Medicine
Bryn Mawr, Pennsylvaniano site contact published
Center of the Health
Corvallis, Oregonno site contact published
Claris Health
Los Angeles, Californiano site contact published
Dr. Christina Enzmann at Easton Advanced Aesthetics and Regenerative Medicine
Easton, Marylandno site contact published
Empire OBGYN
Kenmore, New Yorkno site contact published
Empowered Midwifery and Wellness LLC
Alexandria, Minnesotano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Kimberly Capone, PhD · PRINCIPAL_INVESTIGATOR · Vaginal Biome Science
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Microbiome AnalysisDay 1
To analyze the vaginal microbiome in patients with diverse vaginal health conditions using next-generation sequencing (NGS) and a 56-panel PCR test to understand microbial diversity and implications for disease management.